Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INTRAMUSCULAR | 50MG/ML | 0 | FULVESTRANT | FULVESTRANT |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-05-14 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-03-19 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2021-03-19 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2021-03-19 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2021-03-19 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 15 |
SUPPL | 6 | Null | 15 |
TE Codes
CDER Filings
SANDOZ INC
cder:Array
(
[0] => Array
(
[ApplNo] => 205935
[companyName] => SANDOZ INC
[docInserts] => ["",""]
[products] => [{"drugName":"FULVESTRANT","activeIngredients":"FULVESTRANT","strength":"50MG\/ML","dosageForm":"INJECTABLE;INTRAMUSCULAR","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/14\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-05-14
)
)